Néphrologie

Dr. Öğr. Üyesi Banu Erkalma

Praticien et chercheur Medicana Ataköy İstanbul
Ouvrir la page de l’établissement
Suggérer une correction

Est-ce votre profil ? Revendiquez-le et vérifiez vos informations.

Revendiquer le profil

Personne ↔ Maladie

Sur quels sujets ce médecin travaille-t-il ?

D’après la source

Domaines d’intérêt médical indiqués par le médecin lui-même sur sa page du site de l’établissement. Source : medicana.com.tr.

  • Böbrek nakli ve ilişkili hastalıklar
  • Kronik böbrek yetmezliği
  • Glomerülonefritler
  • Hipertansiyon
  • Diyabet
  • Böbreğin kistik hastalıkları
  • Böbreğin genetik hastalıkları
  • Böbreğin damarsal hastalıkları
  • Diyaliz
  • İdrar yolu hastalıkları
  • İdrarda protein kaçakları ve idrarda kanamalar

CV

Formation et expérience

D’après la source

Expérience

  • 2012-2014Diyarbakır Eğitim Araştırma Hastanesi İç Hastalıklarımedicana.com.tr
  • 2017-2022İstanbul Medeniyet Üniversitesi Prof. Dr. Süleyman Yalçın Şehir Hastanesimedicana.com.tr
  • 2022-2023Medipol Bahçelievler Hastanesimedicana.com.tr
  • 2023-2024Acıbadem International / Acıbadem Fulya Hastanesimedicana.com.tr
  • 2024-2026Biruni Üniversite Hastanesi Nefroloji / Organ Naklimedicana.com.tr

Formation

  • 2006İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesimedicana.com.tr
  • 2012İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, İç Hastalıkları Anabilim Dalımedicana.com.tr
  • 2017İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, Nefroloji Bilim Dalımedicana.com.tr

Confiance

D’où viennent ces informations ?

La source est indiquée à côté de chaque information. Si vous constatez une erreur, vous pouvez suggérer une correction.

  • SpécialitéNéphrologiemedicana.com.trD’après la source
  • ÉtablissementMedicana Ataköymedicana.com.trD’après la source
  • Publications27 publicationspage de profil sur medicana.com.trD’après la source
  • Dernière synchronisation7 novembre 2026 03:26https://www.medicana.com.tr/hekim-detay/27849/banu-erkalmamedicana.com.tr

Travaux scientifiques

Publications

27 publications

  1. A1: Meric K, Bakal N, Şenateş E, Aydın S, Kılıçoğlu ZG, Bahadır Ülger FE, Yencilek E, Erkalma Şenateş B, Şimşek M. Comparison of a 4-Day versus 2-Day Low Fiber Diet Regimen in Barium Tagging CT Colonography in Incomplete Colonoscopy Patients. Gastroenterol Res Pract. 2015;2015:609150. doi: 10.1155/2015/609150.

    Source : page de profil sur medicana.com.tr

  2. A2: RELATIONSHIP BETWEEN SERUM LIPIDS AND COLON POLYPS: A PILOT STUDY KADIR KAYATAŞ, ÖZHAN KAYA, EBUBEKIR ŞENATEŞ, ATAKAN YEŞIL, BANU ERKALMA ŞENATEŞ, EZGI ERSOY YEŞIL, ERDAL BELEN, AKIN DAYAN, REFIK DEMIRTUNÇ. Acta Medica Mediterranea, 2014, 30: 57.

    Source : page de profil sur medicana.com.tr

  3. A3: Ebubekir Şenateş, Abdullah Doğan, Banu Erkalma Şenateş, Erdal Bodakçı, Muhammet Bekçibaşı. An incidental case of biliary fascioliasis mimicking cholangiocellular carcinoma. Infez Med. 2014;22(4):313-6.

    Source : page de profil sur medicana.com.tr

  4. A4: Banu Erkalma Şenateş, Abdullah Doğan, Ebubekir Şenateş. Symptomatic hypocalcaemia following intravenous administration of zoledronic acid in a female patient with osteoporosis. Acta Medica Mediterranea, 2015, 31: 895.

    Source : page de profil sur medicana.com.tr

  5. A5: Senateş E, Colak Y, Yeşil A, Coşkunpinar E, Sahin O, Kahraman Ot, Erkalma Şenateş B, Tuncer I. Circulating Resistin is Elevated in Patients with Non-Alcoholic Fatty Liver Disease and is Associated With Steatosis, Portal İnflammation, İnsulin Resistance And Nonalcoholic Steatohepatitis Scores. Minerva Med. 2012 Oct;103(5):369-76.

    Source : page de profil sur medicana.com.tr

  6. A6: Yalin SF, Gulcicek S, Avci S, Erkalma Senates B, Altiparmak MR, Trabulus S, Alagoz S, Yavuzer H, Doventas A, Seyahi N. Single-frequency and multi-frequency bioimpedance analysis: What is the difference? Nephrology (Carlton). 2018;23(5):438-445. doi: 10.1111/nep.13042.

    Source : page de profil sur medicana.com.tr

  7. A7: Amyloid A Amyloidosis After Renal Transplantation: An Important Cause of Mortality. I, Sarihan I, Caliskan Y, Mirioglu S, Ozluk Y, Senates B, Seyahi N, Basturk T, Yildiz A, Kilicaslan Sever 10.1097/TP.0000000000003043. MS.Transplantation. 2020;104(8):1703-1711. doi:

    Source : page de profil sur medicana.com.tr

  8. A8: Fabry Disease Prevalence in Renal Replacement Therapy in Turkey. Yalın SF, Eren N, Sinangil A, Yilmaz VT, Tatar E, Ucar AR, Sevinc M, Can Ö, Gurkan A, Arik N, Alisir Ecder S, Uyar M, Yasar M, Gulcicek S, Mese M, Dheir H, Cakir U, Köksal Cevher Ş, Turkmen K, Guven B, Guven Taymez D, Erkalma Senates B, Ecder T, Kocak H, Uslu A, Demir E, Basturk T, Ogutmen MB, Kinalp C, Dursun B, Bicik Bahcebasi Z, Sipahi S, Dede F, Oruc M, Caliskan Y, Genc A, Yelken B, Altıparmak MR, Turkmen A, Seyahi N. Nephron. 2019;142(1):26-33. doi: 10.1159/000496620. Epub 2019 Feb 8. PMID: 30739116.

    Source : page de profil sur medicana.com.tr

  9. A9: Visceral Adiposity Index As a Practical Tool in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Vural Keskinler M, Mutlu HH, Sirin A, Erkalma Senates B, Colak Y, Tuncer I, Oguz A. Metab Syndr Relat Disord. 2021 Feb;19(1):26-31. doi: 10.1089/met.2020.0054. Epub 2020 Sep 7. PMID: 32898457.

    Source : page de profil sur medicana.com.tr

  10. A10: Pathogenetic mechanisms of nonalcoholic fatty liver disease and inhibition of the inflammasome as a new therapeutic target. Colak Y, Hasan B, Erkalma B, Tandon K, Zervos X, Menzo EL, Erim T. Clin Res Hepatol Gastroenterol. 2021 Jul;45(4):101710. doi: 10.1016/j.clinre.2021.101710. Epub 2021 Apr 27.

    Source : page de profil sur medicana.com.tr

Voir les 27 publications